Quantum Computing Is Tackling Drug Discovery's Toughest Bottlenecks

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Quantum Computing Is Tackling Drug Discovery's Toughest Bottlenecks

Listen for free

View show details

Episode 73 of The Quantum Computing Podcast explores how quantum computers are beginning to address the molecular simulation challenges that have long stalled pharmaceutical R&D. Lucas and Luna break down the specific bottleneck: classical computers cannot accurately simulate electron correlation in transition-metal catalysts and protein active sites — a problem quantum computers are uniquely suited to solve. They discuss recent results from a collaboration between a major pharma company and a quantum startup that achieved a chemically meaningful simulation of a cytochrome P450 enzyme active site using a 127-qubit processor. The episode covers why this matters for drug metabolism prediction, how error mitigation made the simulation possible, and the timeline for quantum-aided drug design to enter real discovery pipelines. No hype — just a grounded look at where quantum computing meets medicinal chemistry. #QuantumComputing #DrugDiscovery #Pharmaceuticals #MedicinalChemistry #MolecularSimulation #QuantumChemistry #CytochromeP450 #ErrorMitigation #Qubits #QuantumHardware #DrugDesign #ComputationalChemistry #TransitionMetalCatalysis #QuantumStartup #PharmaTech #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

No reviews yet